200 likes | 320 Vues
This document presents a comprehensive overview of the DOPPS (Dialysis Outcomes and Practice Patterns Study) guidelines focusing on the usage of H2 receptor antagonists (H2RAs) and proton pump inhibitors (PPIs). It discusses the background, methodologies, and variables significantly associated with the prescription patterns and comorbidities related to these medications. The analysis includes regional variations in the proportion of patients using H2RAs and PPIs over time, their prescription rates, and the influence of dialysis duration on medication use.
E N D
Variables Significantly Associated with the Use of H2 Receptor Antagonists and Proton Pump Inhibitors
Comorbidities Significantly Associated with the Use of H2 Receptor Antagonists and Proton Pump Inhibitors
Medications Significantly Associated with the Use of H2 Receptor Antagonists and Proton Pump Inhibitors
Plot of Facility Prescription of HAs versus Prescription of PPIs
Percent Use of PPI or HA According to Number of Years on Dialysis